Gayer Charles K
SEC CIK 1800110 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Pres, CCO | 902.6K | $164.1K | $66.5K | 15 | 2021-12-14 | 2025-12-22 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-23 | 2025-12-22 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Pres, CCO | M - OptEx | $5.01 | +74.2K | 902.6K | +9% | +$371.9K |
| D | 2025-12-23 | 2025-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Pres, CCO | F - Tax | $7.41 | -11.5K | 878.4K | -1% | -$85.0K |
| D | 2025-12-19 | 2025-12-17 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Pres, CCO | A - Grant | $0.00 | +471.0K | 889.8K | +112% | $0 |
| 2025-12-16 | 2025-12-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Pres, CCO | F - Tax | $7.57 | -8,181 | 418.8K | -2% | -$61.9K | |
| D | 2024-12-23 | 2024-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | A - Grant | $0.00 | +126.0K | 426.0K | +42% | $0 |
| D | 2024-12-23 | 2024-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | F - Tax | $7.39 | -2,461 | 423.5K | -0.6% | -$18.2K |
| 2024-12-17 | 2024-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | F - Tax | $7.53 | -8,251 | 300.1K | -3% | -$62.1K | |
| 2024-05-15 | 2024-05-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | P - Purchase | $5.47 | +30.0K | 307.5K | +11% | +$164.1K | |
| 2023-12-20 | 2023-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | F - Tax | $6.05 | -2,482 | 274.5K | -0.9% | -$15.0K | |
| D | 2023-12-18 | 2023-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | A - Grant | $0.00 | +34.0K | 282.9K | +14% | $0 |
| D | 2023-12-18 | 2023-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | F - Tax | $6.43 | -5,840 | 277.0K | -2% | -$37.6K |
| D | 2022-12-21 | 2022-12-19 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | A - Grant | $0.00 | +34.0K | 245.6K | +16% | $0 |
| 2022-12-19 | 2022-12-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | S - Sale | $10.90 | -6,100 | 211.6K | -3% | -$66.5K | |
| A | 2022-01-13 | 2021-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | A - Grant | $0.00 | +80.0K | 216.6K | +59% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | Gayer Charles K | Chief Commercial Off | A - Grant | $0.00 | +125.0K | 261.6K | +92% | $0 |
Purchase Sale Sale after option exercise All abbreviations